Correction to: European Journal of Epidemiology (2024) 39:87–96 https://doi.org/10.1007/s10654-023-01073-6
Stockholm–Gotland | Rest of Sweden (control) | |||||
---|---|---|---|---|---|---|
Pre-screening period 2003–2007a | Screening roll-out period 2008–2013 | Widespread screening period 2014–2019 | Period 2003–2007a | Period 2008–2013 | Period 2014–2019 | |
Outcome data | ||||||
Incident cases, n (rate per 100.000 person-years) | 1797 (142.2) | 2571 (141.7) | 2685 (134.9) | 8518 (156.5) | 11,562 (153.4) | 12,681 (158.3) |
Person-years, n | 1,263,655 | 1,814,106 | 1,990,860 | 5,441,196 | 7,535,405 | 8,012,304 |
Population characteristics | ||||||
Educational attainment, % | ||||||
Pre-secondary, ≤ 9 years | 27.5 | 21.9 | 17.8 | 41.5 | 32.4 | 25.0 |
Secondary, > 9 years ≤ 12 years | 39.7 | 40.3 | 40.1 | 38.2 | 42.3 | 45.3 |
Post-secondary, > 12 years | 30.8 | 36.3 | 40.8 | 19.2 | 24.2 | 28.8 |
Missing | 2.0 | 1.5 | 1.2 | 1.2 | 1.0 | 0.9 |
Region of birth, % | ||||||
Nordic country | 88.2 | 87.1 | 83.4 | 94.4 | 93.8 | 92.0 |
Other western country | 3.9 | 3.2 | 2.8 | 1.7 | 1.6 | 1.4 |
Non-western country | 7.9 | 9.7 | 13.8 | 3.9 | 4.6 | 6.6 |
Age groups | ||||||
---|---|---|---|---|---|---|
60–74 years | 60–69 years | 70–74 years | ||||
Model (1) | Model (2) | Model (1) | Model (2) | Model (1) | Model (2) | |
Estimated rate difference | ||||||
Full period | − 3.48 (− 10.36, 3.40) | − 4.09 (− 10.92, 2.74) | 1.43 (− 8.00, 10.87) | 2.20 (− 7.66, 12.06) | − 22.56 (− 38.38, − 6.74) | − 20.69 (− 35.39, − 5.99) |
[0.321] | [0.240] | [0.766] | [0.662] | [0.005] | [0.006] | |
Screening roll-out | 2.59 (− 6.75, 11.92) | 1.28 (− 7.89, 10.45) | 6.90 (− 3.80, 17.61) | 6.77 (− 3.52, 17.06) | − 9.03 (− 29.88, 11.81) | − 8.83 (− 29.43, 11.77) |
[0.587] | [0.784] | [0.206] | [0.197] | [0.396] | [0.401] | |
Widespread screening | − 9.11 (− 18.08, − 0.14) | − 8.96 (− 17.57, − 0.35) | 1.67 (− 8.91, 12.25) | 2.76 (− 8.71, 14.23) | − 25.40 (− 42.97, − 7.83) | − 22.53 (− 39.67, − 5.39) |
[0.047] | [0.041] | [0.757] | [0.637] | [0.005] | [0.010] | |
Placebo test, 2006a | 0.93 (− 11.90, 13.77) | 0.86 (− 11.80, 13.51) | 10.55 (− 4.06, 25.16) | 10.39 (− 4.24, 25.03) | − 13.87 (− 45.12, 17.39) | − 13.73 (− 44.63, − 17.16) |
[0.887] | [0.895] | [0.157] | [0.164] | [0.385] | [0.384] |
Age groups | ||||||
---|---|---|---|---|---|---|
60–74 years | 60–69 years | 70–74 years | ||||
Model (1) | Model (2) | Model (1) | Model (2) | Model (1) | Model (2) | |
Estimated rate difference | ||||||
Full period | − 3.48 (− 10.36, 3.40) | − 4.09 (− 10.92, 2.74) | 1.43 (− 8.00, 10.87) | 2.20 (− 7.66, 12.06) | − 22.56 (− 38.38, − 6.74) | − 20.69 (− 35.39, − 5.99) |
[0.321] | [0.240] | [0.766] | [0.662] | [0.005] | [0.006] | |
Screening roll-out | 2.59 (− 6.75, 11.92) | 1.28 (− 7.89, 10.45) | 6.90 (− 3.80, 17.61) | 6.77 (− 3.52, 17.06) | − 15.40 (− 36.28, 5.49) | − 14.96 (− 35.59, 5.66) |
[0.587] | [0.784] | [0.206] | [0.197] | [0.148] | [0.155] | |
Widespread screening | − 9.11 (− 18.08, − 0.14) | − 8.96 (− 17.57, − 0.35) | 1.67 (− 8.91, 12.25) | 2.76 (− 8.71, 14.23) | − 25.40 (− 42.97, − 7.83) | − 22.53 (− 39.67, − 5.39) |
[0.047] | [0.041] | [0.757] | [0.637] | [0.005] | [0.010] | |
Placebo test, 2006a | 0.93 (− 11.90, 13.77) | 0.86 (− 11.80, 13.51) | 10.55 (− 4.06, 25.16) | 10.39 (− 4.24, 25.03) | − 13.87 (− 45.12, 17.39) | − 13.73 (− 44.63, − 17.16) |
[0.887] | [0.895] | [0.157] | [0.164] | [0.385] | [0.384] |